| Course | Title of Course | Credit | Ref. No. | Section | Day | Hour | Bldg. | Room | Instructor | Consent Required | Seats Remaining | Status |
| 100A | INTROD TOPICS PHARMACY I | 1.0 | 38932 | LEC V0A | T | 2:00P - 3:50P | Piepho,R | No | 0 | CLOSED | ||
| Note: Consent number required at registration Note: Class meets at 4747 Troost room 12 | ||||||||||||
| 101 | PROF SKILL DEVELOPMENT I | 2.0 | 38934 | LEC V0A | TR | 08:30A - 09:20A | HH | 00301 | Marken,P | No | 0 | CLOSED |
| 125 | MEDICAL TERMINOLOGY | 1.0 | 38936 | RSD V0A | ARR | Stoner,S | No | 1 | OPEN | |||
| 151 | INTRO TO PHARMACY LAW | 1.0 | 38938 | LEC V0A | T | 11:00A - 11:50A | HH | 00301 | Brown,W | No | 0 | CLOSED |
| 202 | PHARMACEUTICS I | 4.0 | LEC V0A | MWF | 11:00A - 11:50A | HH | 00301 | Neau,S | No | 6 | OPEN | |
| Note: PHARM 202 SI meets Wed, 10:00 11:00 am in KPB 210. Second year students must successfully complete BCLS prior to enrollment in ANY third year course Note: Any student enrolling in PHARM 202 lab section (1-2) will also be enrolled in PHARM 202 A | ||||||||||||
| 202 | PHARMACEUTICS I | 4.0 | 38942 | LAB V01 | M | 2:00P - 4:50P | Neau,S | No | 5 | OPEN | ||
| Note: PHARM 202 SI meets Wed, 10:00 11:00 am in KPB 210. Second year students must successfully complete BCLS prior to enrollment in ANY third year course Note: Lab meets at 4747 Troost building | ||||||||||||
| 202 | PHARMACEUTICS I | 4.0 | 38944 | LAB V02 | W | 2:00P - 4:50P | Neau,S | No | 1 | OPEN | ||
| Note: PHARM 202 SI meets Wed, 10:00 11:00 am in KPB 210. Second year students must successfully complete BCLS prior to enrollment in ANY third year course Note: Lab meets at 4747 Troost Building | ||||||||||||
| 245 | TOP 200 I | 0.5 | 38946 | LEC V0A | ARR | Lea,J | No | 0 | CLOSED | |||
| Note: Half of the Third Year students will enroll during the fall semester and the remaining Third Years will enroll in the winter semester | ||||||||||||
| 310 | ACADEMIC SERV LEARNING I | 1.0 | 38950 | FLD V0B | ARR | Euler,M | No | 15 | OPEN | |||
| Note: ALL Third Year students MUST enroll fall semester Note: Proof of immunization and BCLS certification required in addition to prerequisites | ||||||||||||
| 313 | CAREER PLANNING | 1.0 | 38952 | LEC V0A | F | 09:00A - 12:00P | Laster,P | No | 1 | OPEN | ||
| Note: Pharm 313 meets only on selected Fridays Note: Class meets at 4747 Troost room 12 | ||||||||||||
| 323 | ISLAM MODERN PRAC MED PH | 1.0 | 38954 | LEC V0A | T | 1:00P - 1:50P | KPB | 00201 | Badr,M | No | 25 | OPEN |
| 341 | MEDICINAL CHEMISTRY I | 3.0 | 38956 | LEC V0A | TR | 09:30A - 10:45A | SCB | 0C213 | Friedman,S | No | 0 | CLOSED |
| Note: Pharm 341 tests will be held outside or regular class time on Fridays from 1-2pm in KPB 201 and 301 Note: Additional recitation discussion will be held on Fri from 1-2pm in KPB 301 | ||||||||||||
| 345 | TOP 200 II | 0.5 | 38958 | RSD V0A | ARR | Lea,J | No | 7 | OPEN | |||
| 361 | PHARMACOLOGY I | 4.0 | 38960 | LEC V0A | MWF | 1:00P - 2:50P | RH | 00104 | Igwe,O | No | 19 | OPEN |
| 377 | PRINCLPS/NUTRTN SUPPORT | 2.0 | 38962 | LEC V0A | W | 10:00A - 11:50A | KPB | 00201 | Wormington,D | No | 3 | OPEN |
| Note: Fourth professional year students must have completed a minimum of 10.0 credit hours of professional electives prior to enrolling in final year experimental rotations. | ||||||||||||
| 380 | ACADEMIC SERV LEARN II | 1.0 | 38964 | FLD V0A | ARR | Euler,M | No | 0 | CLOSED | |||
| 389 | ADV IN DRUG THERAPY | 2.0 | 38966 | LEC V0A | MW | 1:00P - 1:50P | SCB | 0C213 | Mitra,A | No | 5 | OPEN |
| 397 | HOME HEALTH CARE | 2.0 | 38968 | LEC V0A | T | 10:00A - 11:50A | Bodanske,B | No | 1 | OPEN | ||
| Note: Class meets at KPB 1C | ||||||||||||
| 404P | DRUG INFO CLERKSHIP | 4.0 | 38970 | FLD XCB | ARR | Brown,W | No | 10 | OPEN | |||
| 404P | DRUG INFO CLERKSHIP | 4.0 | 38972 | FLD V0A | ARR | Euler,M | No | 34 | OPEN | |||
| 406P | GENERAL MED I | 4.0 | 38974 | FLD V0A | ARR | Euler,M | No | 21 | OPEN | |||
| 407P | GEN MED II (AMBUL CARE) | 6.0 | 38976 | FLD V0A | ARR | Euler,M | No | 31 | OPEN | |||
| 409P | HLTH SYSTEMS CLERKSHIP | 4.0 | 38978 | FLD V0A | ARR | Euler,M | No | 27 | OPEN | |||
| 410P | GENERAL MEDICINE III | 4.0 | 38980 | FLD V0A | ARR | Euler,M | No | 42 | OPEN | |||
| 412P | COMM PHARM PRAC CLERKSHP | 4.0 | 38982 | FLD V0A | ARR | Euler,M | No | 26 | OPEN | |||
| 418P | ELECTIVE CLERKSHIP | 4.0 | 38984 | FLD V0A | ARR | Euler,M | No | 27 | OPEN | |||
| 419P | DIR INDV ROT PHM PRAC II | 4.0 | 38986 | FLD V0A | ARR | Staff | No | 70 | OPEN | |||
| 420 | PHARMACOTHERAPY II | 7.0 | LEC V0A | MW | 2:00P - 4:50P | RH | 00104 | Graham,M | No | 1 | OPEN | |
| 420 | PHARMACOTHERAPY II | 7.0 | 38990 | FLD V01 | R | 2:00P - 4:50P | HH | 00301 | Graham,M | No | 1 | OPEN |
| 420P | DIR IND ROT PHR PRAC III | 4.0 | 38992 | FLD V0A | ARR | Euler,M | No | 10 | OPEN | |||
| 421P | DIR IND ROT PHR PRAC IV | 4.0 | 38994 | FLD V0A | ARR | Euler,M | No | 10 | OPEN | |||
| 424 | INTRO NAT PRODUCT THERAP | 2.0 | 38996 | LEC V0A | M | 10:00A - 11:50A | KPB | 00301 | McQueen,C | No | 11 | OPEN |
| 427 | HOSPITAL PHARMACY | 2.0 | 38998 | LEC V0A | R | 08:00A - 09:50A | DeJong,D | No | 4 | OPEN | ||
| Note: Class meets in KPB 1C | ||||||||||||
| 451 | PHARMACY LAW & ETHICS | 2.0 | 39000 | LEC V0A | T | 2:00P - 3:50P | HH | 00301 | Brown,W | No | 5 | OPEN |
| 465 | ECONOMICS OF HLTH & MED | 3.0 | 39002 | LEC V0A | M | 2:00P - 4:50P | RH | 00111 | Rasu,R | No | 19 | OPEN |
| 484P | PHARMACY SEMINAR | 1.0 | 39004 | FLD V0A | W | 3:00P - 5:00P | McQueen,C | Yes | 10 | OPEN | ||
| Note: Consent number required at registration. Note: Class meets at the Med School | ||||||||||||
| 489B | SPECIAL TOPICS PHARMACY | 2.0 | 39005 | LEC V0A | ARR | Euler,M | No | 0 | CLOSED | |||
| Topic: Pharmacy Based Immunization Delivery | ||||||||||||
| 489E | SPECIAL TOPICS PHARMACY | 1.0-5.0 | 39006 | LEC V0A | W | 3:00P - 4:50P | BLOCH | 00004 | Hewins,J | No | 0 | CLOSED |
| Topic: Computers in Pharmacy | ||||||||||||
| 497A | DIR INDV STUDY PHARMACY | 1.0-4.0 | 39008 | I S V0A | ARR | Staff | Yes | 0 | CLOSED | |||
| 497C | DIR IND ST PHRMCEUT CHM | 1.0-4.0 | 39010 | I S V0A | ARR | Friedman,S | No | 0 | CLOSED | |||
| 497D | DIR IND ST PHARMACOLOGY | 1.0-4.0 | 39012 | I S V0A | ARR | Staff | Yes | 0 | CLOSED | |||
| 497E | DIR IND ST-CLINICAL PHAR | 1.0-4.0 | 39014 | I S V0A | ARR | Obering,C | Yes | 0 | CLOSED | |||
| 507 | BASIC PHARMACOLOGY | 3.0 | 39016 | LEC V0A | TWR | 08:00A - 08:50A | Badr,M | No | 20 | OPEN | ||
| Note: Class meets at the Dental School, room 202 | ||||||||||||
| 519 | PHARMACOLOGY I | 4.0 | 39018 | LEC V0A | MWF | 1:00P - 2:50P | RH | 00104 | Igwe,O | No | 26 | OPEN |
| 521 | ADV ORGANIC MED CHEM | 3.0 | 39020 | LEC V0A | TR | 2:00P - 3:30P | KPB | 00201 | Friedman,S | No | 0 | CLOSED |
| 527 | ANALYTICAL METHODS | 3.0 | 39021 | LEC V0A | WF | 09:30A - 10:45A | KPB | 00002 | Gutheil,W | No | 5 | OPEN |
| 580A | SEM IN PHARMACEUTICL SCI | 1.0 | 39022 | RSD V0A | R | 4:00P - 5:00P | KPB | 00201 | Mitra,A | No | 42 | OPEN |
| 580C | SEMNR IN PHARMC/TOXICOLG | 1.0 | 39024 | RSD V0A | W | 4:00P - 5:15P | Mark,K | No | 48 | OPEN | ||
| Note: Class meets at the Med School | ||||||||||||
| 590BB | ST: TOXICOLOGY | 1.0-3.0 | 39026 | I S V0A | ARR | Staff | No | 0 | CLOSED | |||
| 590C | SPEC TOP PHARMACOLOGY | 1.0-3.0 | I S V0A | ARR | Lau,Y | No | 15 | OPEN | ||||
| Topic: Advanced Neuropharmacology | ||||||||||||
| 599A | RSCH & THESIS PHARM | 1.0-9.0 | 39030 | I S V0A | ARR | Lee,C | No | 14 | OPEN | |||
| 599A | RSCH & THESIS PHARM | 1.0-9.0 | 39032 | I S V0B | ARR | Staff | No | 15 | OPEN | |||
| 599A | RSCH & THESIS PHARM | 1.0-9.0 | 39034 | I S V0C | ARR | Friedman,S | No | 15 | OPEN | |||
| 599A | RSCH & THESIS PHARM | 1.0-9.0 | 39036 | I S V0D | ARR | Tombran-Tink,J | No | 15 | OPEN | |||
| 599A | RSCH & THESIS PHARM | 1.0-9.0 | 39038 | I S V0E | ARR | Mitra,A | No | 15 | OPEN | |||
| 599A | RSCH & THESIS PHARM | 1.0-9.0 | 39040 | I S V0F | ARR | Neau,S | No | 13 | OPEN | |||
| 599A | RSCH & THESIS PHARM | 1.0-9.0 | 39042 | I S V0G | ARR | Johnston,T | No | 15 | OPEN | |||
| 599A | RSCH & THESIS PHARM | 1.0-9.0 | 39044 | I S V0H | ARR | Gutheil,W | No | 15 | OPEN | |||
| 599BB | RSCH & THESIS TOXICOLOGY | 1.0-9.0 | 39046 | I S V0A | ARR | Staff | No | 20 | OPEN | |||
| 599C | RSCH & THES PHARMACOL | 1.0-9.0 | 39048 | I S V0A | ARR | Lau,Y | No | 10 | OPEN | |||
| 599C | RSCH & THES PHARMACOL | 1.0-9.0 | 39050 | I S V0B | ARR | Kearns,G | No | 10 | OPEN | |||
| 599C | RSCH & THES PHARMACOL | 1.0-9.0 | 39052 | I S V0C | ARR | Piepho,R | No | 10 | OPEN | |||
| 599C | RSCH & THES PHARMACOL | 1.0-9.0 | 39054 | I S V0D | ARR | Badr,M | No | 10 | OPEN | |||
| 599C | RSCH & THES PHARMACOL | 1.0-9.0 | 39056 | I S V0E | ARR | Igwe,O | No | 9 | OPEN | |||
| 599C | RSCH & THES PHARMACOL | 1.0-9.0 | 39058 | I S V0F | ARR | Wang,J | No | 10 | OPEN | |||
| 599C | RSCH & THES PHARMACOL | 1.0-9.0 | 39060 | I S V0G | ARR | Staff | No | 10 | OPEN | |||
| 599C | RSCH & THES PHARMACOL | 1.0-9.0 | 39062 | I S V0H | ARR | Mark,K | No | 10 | OPEN | |||
| 599C | RSCH & THES PHARMACOL | 1.0-9.0 | 39064 | I S V0I | ARR | Scheuer,D | No | 10 | OPEN | |||
| 599C | RSCH & THES PHARMACOL | 1.0-9.0 | 39066 | I S V0J | ARR | Wang,Q | No | 9 | OPEN | |||
| 615 | METH IN PHARM&TOXICOLOGY | 3.0 | 39068 | I S V0A | ARR | Scheuer,D | No | 10 | OPEN | |||
| Note: Contact instructor to schedule rotations | ||||||||||||
| 631 | PHARM FORMULATIONS I | 3.0 | 39070 | LEC V0A | TR | 11:00A - 12:15P | SCB | 0C214 | Lee,C | No | 12 | OPEN |
| 690A | SPEC TOPICS PHARM | 1.0-3.0 | 39072 | I S V0A | A | Tombran-Tink,J | No | 15 | OPEN | |||
| 690A | SPEC TOPICS PHARM | 1.0-3.0 | 39074 | I S V0B | ARR | Staff | No | 10 | OPEN | |||
| 690A | SPEC TOPICS PHARM | 1.0-3.0 | 39076 | I S V0C | ARR | Lee,C | No | 10 | OPEN | |||
| 690A | SPEC TOPICS PHARM | 1.0-3.0 | 39078 | I S V0D | ARR | Friedman,S | No | 10 | OPEN | |||
| 690A | SPEC TOPICS PHARM | 1.0-3.0 | 39080 | I S V0E | ARR | Neau,S | No | 9 | OPEN | |||
| 690A | SPEC TOPICS PHARM | 1.0-3.0 | 39082 | I S V0F | ARR | Mitra,A | No | 10 | OPEN | |||
| 690A | SPEC TOPICS PHARM | 1.0-3.0 | 39084 | I S V0G | ARR | Johnston,T | No | 10 | OPEN | |||
| 690A | SPEC TOPICS PHARM | 1.0-3.0 | 39086 | I S V0H | ARR | Gutheil,W | No | 10 | OPEN | |||
| 690BB | ST: TOXICOLOGY | 1.0-3.0 | 39088 | I S V0A | ARR | Staff | No | 20 | OPEN | |||
| 690C | SPEC TPS PHARMACOLOGY | 1.0-3.0 | 39090 | I S V0A | ARR | Staff | No | 10 | OPEN | |||
| 690C | SPEC TPS PHARMACOLOGY | 1.0-3.0 | 39092 | I S V0B | ARR | Kearns,G | No | 10 | OPEN | |||
| 690C | SPEC TPS PHARMACOLOGY | 1.0-3.0 | 39094 | I S V0C | ARR | Piepho,R | No | 10 | OPEN | |||
| 690C | SPEC TPS PHARMACOLOGY | 1.0-3.0 | 39096 | I S V0D | ARR | Badr,M | No | 9 | OPEN | |||
| 690C | SPEC TPS PHARMACOLOGY | 1.0-3.0 | 39098 | I S V0E | ARR | Igwe,O | No | 10 | OPEN | |||
| 690C | SPEC TPS PHARMACOLOGY | 1.0-3.0 | 39100 | I S V0F | ARR | Lau,Y | No | 10 | OPEN | |||
| 690C | SPEC TPS PHARMACOLOGY | 1.0-3.0 | 39102 | I S V0G | ARR | Staff | No | 10 | OPEN | |||
| 699A | RESCH&DISERTATN-PHARMACY | 1.0-16.0 | 39104 | I S V0A | ARR | Tombran-Tink,J | No | 13 | OPEN | |||
| 699A | RESCH&DISERTATN-PHARMACY | 1.0-16.0 | 39106 | I S V0B | ARR | Staff | No | 15 | OPEN | |||
| 699A | RESCH&DISERTATN-PHARMACY | 1.0-16.0 | 39108 | I S V0C | ARR | Lee,C | No | 15 | OPEN | |||
| 699A | RESCH&DISERTATN-PHARMACY | 1.0-16.0 | 39110 | I S V0D | ARR | Neau,S | No | 8 | OPEN | |||
| 699A | RESCH&DISERTATN-PHARMACY | 1.0-16.0 | 39112 | I S V0E | ARR | Mitra,A | No | 3 | OPEN | |||
| 699A | RESCH&DISERTATN-PHARMACY | 1.0-16.0 | 39114 | I S V0F | ARR | Johnston,T | No | 10 | OPEN | |||
| 699A | RESCH&DISERTATN-PHARMACY | 1.0-16.0 | 39116 | I S V0G | ARR | Friedman,S | No | 14 | OPEN | |||
| 699A | RESCH&DISERTATN-PHARMACY | 1.0-16.0 | 39118 | I S V0H | ARR | Gutheil,W | No | 15 | OPEN | |||
| 699B | RES & DISSER PHARM CHEM | 1.0-16.0 | 39120 | I S V0A | ARR | Friedman,S | No | 10 | OPEN | |||
| 699BB | RSRCH & DISS TOXICOLOGY | 1.0-16.0 | 39122 | I S V0A | ARR | Staff | No | 10 | OPEN | |||
| 699C | RES & DISSER PHARMACOL | 1.0-16.0 | 39124 | I S V0A | ARR | Kearns,G | No | 10 | OPEN | |||
| 699C | RES & DISSER PHARMACOL | 1.0-16.0 | 39126 | I S V0B | ARR | Piepho,R | No | 10 | OPEN | |||
| 699C | RES & DISSER PHARMACOL | 1.0-16.0 | 39128 | I S V0C | ARR | Badr,M | No | 10 | OPEN | |||
| 699C | RES & DISSER PHARMACOL | 1.0-16.0 | 39130 | I S V0D | ARR | Igwe,O | No | 10 | OPEN | |||
| 699C | RES & DISSER PHARMACOL | 1.0-16.0 | 39132 | I S V0E | ARR | Lau,Y | No | 10 | OPEN | |||
| 699C | RES & DISSER PHARMACOL | 1.0-16.0 | 39134 | I S V0F | ARR | Wang,J | No | 10 | OPEN | |||
| 699C | RES & DISSER PHARMACOL | 1.0-16.0 | 39136 | I S V0G | ARR | Mark,K | No | 10 | OPEN | |||
| 699C | RES & DISSER PHARMACOL | 1.0-16.0 | 39138 | I S V0H | ARR | Scheuer,D | No | 10 | OPEN | |||
| 699C | RES & DISSER PHARMACOL | 1.0-16.0 | 39140 | I S V0I | ARR | Staff | No | 10 | OPEN | |||
| 699C | RES & DISSER PHARMACOL | 1.0-16.0 | 39142 | I S V0J | ARR | Wang,Q | No | 9 | OPEN | |||